Multi-center Prospective Study on E-NOTES for Myomectomy With Traction of Multidirectional Sutures (E-NOTES)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01829022 |
Recruitment Status :
Completed
First Posted : April 11, 2013
Last Update Posted : June 26, 2014
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Primary objectives : To investigate technical feasibility and postoperative morbidity after E-NOTES for Myomectomy with Traction of Multidirectional Sutures
Secondary objectives : To investigate postoperative pain after E-NOTES for Myomectomy with Traction of Multidirectional Sutures by clinical variables such as incision size, type of port, size and number of myoma, or operation time.
Condition or disease | Intervention/treatment |
---|---|
Myoma | Procedure: E-NOTES |
- Leiomyoma is a common benign tumor of the smooth muscle cells of the myometrium.1 It can cause several symptoms such as abnormal vaginal bleeding, pain, or urinary symptoms according to size and location. Steadily, lesser invasive surgeries have been preferred for such benign disease (laparotomy, laparoscopy, and then single-port surgery).2,3
- However, these minimal approaches, laparoscopic morcellation of preoperatively suspicious leimyoma, have the potential risk of peritoneal seeding of postoperative diagnosed leiomyosarcoma in the pathological examination.4 Currently, safe morcellation is also required during myomectomy while using a lesser invasive surgical approach such as single-port surgery or natural orifice transumbilical endoscopic surgery (NOTES).
- During single-port surgery or embryonic NOTES (E-NOTES) via an umbilicus, handling of myoma into different directions could be quite a big challenge. Fortunately, myoma is enough hard to pull with string and has a tendency not to rupture during manipulation of these strings.
- These concepts lead to traction of anchoring sutures during E-NOTES for myomectomy applied in the current case. Safe morcellation could be guaranteed, because direction morcellation via an umbilicus is possible in an endobag.
- This useful and safe surgical approach needs to be confirmed in multi-centers in terms of feasibility and morbidity.
Study Type : | Observational |
Actual Enrollment : | 35 participants |
Observational Model: | Case-Only |
Time Perspective: | Prospective |
Official Title: | Multi-center Prospective Study on Embryonic-Natural Orifice Transumbilical Endoscopic Surgery for Myomectomy With Traction of Multidirectional Sutures |
Study Start Date : | April 2013 |
Actual Primary Completion Date : | April 2014 |
Actual Study Completion Date : | April 2014 |

Group/Cohort | Intervention/treatment |
---|---|
E-NOTES
Embryonic-Natural Orifice Transumbilical Endoscopic Surgery for Myomectomy with Traction of Multidirectional Sutures
|
Procedure: E-NOTES
Embryonic-Natural Orifice Transumbilical Endoscopic Surgery for Myomectomy with Traction of Multidirectional Sutures
Other Name: Embryonic-Natural Orifice Transumbilical Endoscopic Surgery |
- Technical feasibilities and postoperative morbidity after E-NOTES for Myomectomy with Traction of Multidirectional Sutures [ Time Frame: Postoperative surveillance including pain evaluation as routine clinical practise for 1 months ]Technical feasibility and postoperative morbidity will be evaluated in terms of overall or institutional conversion rate to convetional multi-port laparoscopy or laparotomy, operation time for each surgical procedures: dissection, morecellation, suturing, and total surgical procedures, complication, change of hemoglobin, and estimated blood loss
- Postoperative pain after E-NOTES for Myomectomy with Traction of Multidirectional Sutures by clinical variables such as incision size, type of port, size and number of myoma, or operation time. [ Time Frame: Preoperative and postoperative pain ]Visual analogue scale will be used for pain evaluation: preoperative, postoperative 24 hour, postoperative 48 hour, postoperative 10 day (7 to 10 day), and postoperative 28 day (21 to 35 day).

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 20 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Women who are surgically candidate for myomectomy
- Age > 20 years
Exclusion Criteria:
- Contraindications for laparoscopic surgery and/or general anesthesia.
- Greater than five fibroids sized of 3cm or more
- Uterus extending beyond the umbilicus
- Major medical comorbidity or psychiatric illness, which could affect follow-up and/or compliance
- Patients undergoing concomitant complex surgical procedures at the time of myomectomy (such as resection of severe endometriosis etc.)
- Pregnancy
- Patients with any suggestion of malignancy in the pelvis
- Patients with cooperation of another main surgical procedures such as severe adhesiolysis or low anterior resection
- Patients who are severely anemic or who have significant medical conditions such as cardiac or pulmonary disease
- Patients who refuse to participate or give consent to the procedures

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01829022
Korea, Republic of | |
National Cancer Center | |
Goyang, Gyeonggi, Korea, Republic of | |
National Cancer Center | |
Koyang-si, Korea, Republic of |
Principal Investigator: | Myong Cheol Lim, MD, PhD | National Cancer Center |
Responsible Party: | Myong Cheol Lim, Senior researcher, National Cancer Center, Korea |
ClinicalTrials.gov Identifier: | NCT01829022 |
Other Study ID Numbers: |
NCCNCS-13-MAR |
First Posted: | April 11, 2013 Key Record Dates |
Last Update Posted: | June 26, 2014 |
Last Verified: | June 2014 |
Myoma Uterine myomectomy |
Myoma Neoplasms, Muscle Tissue Neoplasms, Connective and Soft Tissue Neoplasms by Histologic Type Neoplasms |